Disseminated Cryptococcosis in a 63-year-old Patient with Multiple Sclerosis Treated with Fingolimod
Author:
Affiliation:
1. Department of General Internal Medicine, Kobe University Hospital, Japan
2. Division of Health Sciences, Department of Community Health Sciences, Kobe University Graduate School of Health Sciences, Japan
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/internalmedicine/55/22/55_55.7255/_pdf
Reference19 articles.
1. 1. Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am 20: 507-544, v-vi, 2006.
2. 2. Kappos L, Antel J, Comi G, et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 355: 1124-1140, 2006.
3. 3. Ratchford JN, Costello K, Reich DS, Calabresi PA. Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod. Neurology 79: 2002-2004, 2012.
4. 4. Arvin AM, Wolinsky JS, Kappos L, et al. Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management. JAMA Neurol 72: 31-39, 2015.
5. 5. Huang D. Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod. Neurology 85: 1001-1003, 2015.
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cryptococcosis Associated With Biologic Therapy: A Narrative Review;Open Forum Infectious Diseases;2024-06-26
2. Cryptococcal meningoencephalitis in multiple sclerosis treated with fingolimod;Practical Neurology;2023-10-06
3. Cutaneous presentation of cryptococcal infection with subclinical central nervous system involvement secondary to fingolimod therapy;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2023-07
4. Orofacial Cryptococcosis: A Challenging Clinical Report and a Systematic Analysis of the Literature;International Journal of Surgical Pathology;2023-05-04
5. Current status and new developments in sphingosine-1-phosphate receptor antagonism: fingolimod and more;Expert Opinion on Drug Metabolism & Toxicology;2022-10-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3